Unlocking Japan's rare disease market

WEDNESDAY, NOVEMBER 19, 2025 |  11:00 AM - 1:00 PM ET

Japan offers a strong foundation for rare disease R&D — and it’s worth a closer look. With a regulatory framework that rivals the US and Europe, Japan provides compelling opportunities for companies looking to expand their orphan drug portfolios.

Our upcoming virtual event brings together PMDA officials and industry veterans to break down what it takes to navigate Japan: from regulatory pathways and patient access to reimbursement strategies.

Whether you’re exploring new territories or fine-tuning your Japan entry strategy, this session delivers the guidance you need to make your next move count.